Total (n = 346) | DOAC (n = 74) | Vitamin K antagonist (n = 272) | p | ||||
---|---|---|---|---|---|---|---|
PCC (units), [median (IQR)] | 2100 | (1800-2400) | 2000 | (1700–3000) | 2100 | (1800-2400) | 0.346 |
ECs given | 48 | (13.9) | 15 | (20.3) | 33 | (12.1) | 0.073 |
Number of ECs | |||||||
1 | 23 | (6.7) | 6 | (8.2) | 17 | (6.2) | |
2 | 14 | (4.1) | 3 | (4.1) | 11 | (4.0) | |
3 | 7 | (2.0) | 4 | (5.5) | 3 | (1.1) | |
4 | 2 | (0.6) | 2 | (2.7) | 0 | (0.0) | |
5 | 2 | (0.6) | 0 | (0.0) | 2 | (0.7) | 0.014 |
Platelet concentrates | 5 | (1.4) | 2 | (2.7) | 3 | (1.1) | 0.307 |
Fresh frozen plasma | 19 | (5.5) | 6 | (8.1) | 13 | (4.8) | 0.265 |
Tranexamic acid | 41 | (11.8) | 21 | (28.4) | 20 | (7.4) | < 0.001 |